<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Phenazopyridine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../sickbay-shared.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Phenazopyridine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Other</div>
      <h1>Phenazopyridine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Phenazopyridine 200mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Symptomatic relief of urinary tract discomfort (dysuria, urgency, frequency, burning)</strong>
            <ul>
              <li>200 mg PO 3 times daily after meals</li>
              <li><strong>Maximum duration: 2 days</strong> (symptomatic relief only; does not treat infection)</li>
              <li>Use as adjunct to antibiotics when treating UTI; discontinue when symptoms improve (typically within 48 hours)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Symptomatic relief of pain, burning, urgency, frequency associated with lower urinary tract irritation</li>
          <li>Adjunct to antibiotics in urinary tract infection (does NOT treat infection; provides only symptom relief)</li>
          <li>Post-procedural urinary discomfort (catheterization, cystoscopy)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to phenazopyridine</li>
          <li>Renal insufficiency (CrCl &lt;50 mL/min or significant renal disease): contraindicated due to accumulation risk</li>
          <li>Hepatic disease: use with caution</li>
          <li>Glucose-6-phosphate dehydrogenase (G6PD) deficiency: risk of hemolytic anemia</li>
          <li>Pregnancy: limited data; use only if clearly needed</li>
          <li>Not for long-term use (treats symptoms only, not underlying condition)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Headache, dizziness, GI upset</li>
          <li>Orange-red discoloration of urine (expected; counsel patient to avoid alarm)</li>
          <li>Staining of contact lenses possible</li>
          <li>Rare but serious: methemoglobinemia (cyanosis, shortness of breath), hemolytic anemia (especially in G6PD deficiency), hepatotoxicity, renal toxicity</li>
          <li>Hypersensitivity reactions (rash, pruritus)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Take with or after food to minimize GI upset</li>
          <li>Counsel patient: urine will turn orange or red (normal effect; will stain clothing/underwear)</li>
          <li>Emphasize this is symptomatic relief only; must take full antibiotic course if UTI is being treated</li>
          <li>Stop after 2 days or when symptoms resolve (whichever comes first)</li>
          <li>If symptoms persist beyond 2 days, reassess for inadequate antibiotic therapy or alternate diagnosis</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom improvement (dysuria, urgency, frequency) within 24â€“48 hours</li>
          <li>If no improvement or worsening symptoms (fever, flank pain, hematuria): reassess for pyelonephritis or complicated infection</li>
          <li>Watch for signs of methemoglobinemia (cyanosis, dyspnea, gray-brown skin discoloration) or hemolysis (pale, jaundice, dark urine beyond expected orange-red color)</li>
          <li>Discontinue immediately if hypersensitivity reaction or serious adverse effect</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Ensure UTI diagnosis confirmed (or strongly suspected) and appropriate antibiotics initiated before using phenazopyridine</li>
          <li>This medication does NOT treat infection; it only masks symptoms temporarily</li>
          <li>Document baseline renal function if known; avoid in patients with known renal disease</li>
          <li>If limited diagnostic capability: use with caution and reassess early if no clinical improvement</li>
          <li>Counsel patient about urine discoloration to prevent unnecessary alarm or misinterpretation as hematuria</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (phenazopyridine): <a href="https://pdf.hres.ca/dpd_pm/00066997.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00066997.PDF</a></li>
          <li>Medscape drug reference (phenazopyridine): <a href="https://reference.medscape.com/drug/pyridium-phenazopyridine-342701" target="_blank" rel="noopener">https://reference.medscape.com/drug/pyridium-phenazopyridine-342701</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
